Call: 1-702-907-0615

LATEST ENZYME BIOSYSTEMS PRESS RELEASE & NEWS

Press Releases

Unregistered Sale of Equity Securities, Other Events

On June 9, 2014, EnzymeBiosSystems (“the Company” or the Registrant”) closed its Regulation S Offering, whereby, the Company sold 12,783,587 shares of unregistered restricted common stock to six foreign purchasers, at a price of $0.0766 per share. The total amount the Company received from this Offering was $980,000.


Change in Directors or Principal Officers

Change in Directors or Principal Officers Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers On June 2, 2014, the Board of Directors of EnzymeBioSystems (the “Company” or the “Registrant”) unanimously appointed Mr. Gary Rojewski as Chief Executive Officers of the Company. Mr. Rojewski accepted the position. He will […]


Form 10-Q for ENZYMEBIOSYSTEMS

Form 10-Q for ENZYMEBIOSYSTEMS 14-May-2014 Quarterly Report MANAGEMENT’S DISCUSSION AND ANALYSIS OF   FINANCIAL CONDITION AND RESULTS OF OPERATIONS Item 2. – Management’s Discussion and Analysis of Financial Condition and Results of Operations Forward-Looking Information This Quarterly Report on Form 10-Q contains forward-looking statements. When used in this Quarterly Report on Form 10-Q, the words […]